Format

Send to:

Choose Destination
See comment in PubMed Commons below
Anesth Analg. 2008 Aug;107(2):620-4. doi: 10.1213/ane.0b013e3181770b42.

The pivotal role of vasopressin in refractory anaphylactic shock.

Author information

  • 1Department for Anesthesiology and Intensive Care Medicine, SRH Zentralklinikum Suhl, Albert-Schweitzer str. 2, 98527 Suhl, Germany. cwsm.schummer@gmx.de

Abstract

BACKGROUND:

Severe anaphylaxis can be associated with cardiovascular collapse that is difficult to manage and does not respond to treatment with epinephrine. Because anaphylaxis is uncommon, unpredictable and may be fatal, a prospective, randomized, controlled trial in humans on the best management is difficult and guidelines are based on theory and anecdotes only.

METHODS AND RESULTS:

We report six cases in which the use of vasopressin was successful in the treatment of anaphylactic shock.

CONCLUSIONS:

Standard treatment of anaphylactic shock, including discontinuation of the causative agent, administration of epinephrine, and infusion of IV fluids, did not stabilize cardiocirculatory function, and adding arginine vasopressors resulted in prompt hemodynamic stabilization.

Comment in

PMID:
18633042
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk